"Eligible patients for this study were healthy women with >/= 17% lifetime risk of breast cancer or with a mutation in BRCA1 or BRCA2. A total of 632 women were screened between 2002 and 2012 (each for 6 years). During the study 30 women were diagnosed with breast cancer with 10 of these diagnoses occurring between screening visits and six of the 10 diagnosed women were gene carriers"xsd:string